
The Union Budget 2026-27 has increased the allocation for Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (PM-JAY), reaffirming the Centre’s continued fiscal backing for publicly financed healthcare and hospital coverage for vulnerable households.
Finance Minister Nirmala Sitharaman set the net allocation for PM-JAY at ₹9,500 crore for FY27. This compares with ₹9,406 crore in FY26 Budget Estimates and ₹9,000 crore in FY26 Revised Estimates.
The latest figure marks a 5.5% rise over the revised FY26 number, indicating steady upward funding support. Budget records show a consistent rise over recent years, ₹7,178.64 crore in FY25 actuals, followed by higher budgeted support in FY26 and FY27, reflecting sustained priority status for the scheme.
Budget documents outline the internal structure behind the allocation. The gross provision under PM-JAY includes ₹9,499 crore on the revenue side and ₹1 crore under capital.
A transfer of ₹5,000 crore is routed through the Pradhan Mantri Swasthya Suraksha Nidhi, with an equivalent adjustment shown against scheme funding, resulting in a net support figure of ₹9,500 crore.
This mechanism continues to function as a funding stabiliser for large national health programmes.
No major benefit expansion or redesign has been announced this year. Instead, the focus appears to be on maintaining claim settlement capacity, operational stability and payout continuity.
PM-JAY continues to offer ₹5 lakh per family per year for cashless secondary and tertiary hospital treatment and remains a major demand channel for empanelled public and private hospitals, particularly in high-value specialties such as cardiology, oncology and orthopaedics.
Read More: Union Budget 2026: FM Announces 20 Years Tax Holiday for GIFT City Units!
The higher FY27 allocation signals continuity and consolidation, positioning PM-JAY as a stable core pillar of India’s publicly funded healthcare framework.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Feb 2, 2026, 2:22 PM IST

Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
